William Rote
Senior Vice President of Research and Development
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | $522,334 | $2,256,465 |
| 2024 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | $502,834 | $1,516,646 |
| 2023 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | $488,417 | $2,053,099 |
| 2022 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | $470,204 | $2,033,381 |
| 2021 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Head of Research and Development | $460,881 | $1,946,740 |
| 2020 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Head of Research and Development | $447,474 | $1,657,674 |
| 2019 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Head of Research and Development | $432,858 | $1,310,226 |
| 2018 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Head of Research and Development | $420,250 | $1,618,525 |
| 2017 | Travere Therapeutics, Inc. (TVTX) | Senior Vice President and Head of Research and Development | $363,481 | $1,853,644 |
Earnings-call appearances
-
Travere Therapeutics, Inc. Q3 FY2025 Earnings Call2025-10-30
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-06
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-01
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-20
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-15
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-04
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-09
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q3 FY2022 Earnings Call2022-10-27
Travere Therapeutics, Inc. (TVTX)
-
Travere Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Travere Therapeutics, Inc. (TVTX)